about
Role of interventional pulmonology in the management of complicated parapneumonic pleural effusions and empyemaCurrent understanding in source control management in septic shock patients: a reviewIntrapleural tissue plasminogen activator and deoxyribonuclease therapy for pleural infectionPneumonia and empyema: causal, casual or unknownIntrapleural adenoviral delivery of human plasminogen activator inhibitor-1 exacerbates tetracycline-induced pleural injury in rabbits.Survey of childhood empyema in Asia: implications for detecting the unmeasured burden of culture-negative bacterial disease.Direct Streptococcus pneumoniae real-time PCR serotyping from pediatric parapneumonic effusions.Thoracic empyema: a 12-year study from a UK tertiary cardiothoracic referral centre.Prevention of pneumococcal diseases in the post-seven valent vaccine era: a European perspective.Positive predictive value of the ICD-10 hospital diagnosis of pleural empyema in the Danish National Registry of Patients.Update on the success of the pneumococcal conjugate vaccinePaediatric complicated pneumonia: Diagnosis and management of empyema.Pleural infection-current diagnosis and management.Characterization of a new mouse model of empyema and the mechanisms of pleural invasion by Streptococcus pneumoniae.Carers' perspectives on the presentation of community-acquired pneumonia and empyema in children: a case seriesEmergence of parapneumonic empyema in the USA.Distribution of Streptococcus pneumoniae serotypes that cause parapneumonic empyema in Turkey.Safety and Efficacy of Intrapleural Tissue Plasminogen Activator and DNase during Extended Use in Complicated Pleural Space Infections.Pleural Empyema and Aortic Aneurysm: A Retrospective National Population-Based Cohort Study.Setting up a specialist pleural disease service.Interventional radiology of pleural diseases.Pleural infection: changing bacteriology and its implications.Management of infectious processes of the pleural space: a review.Parapneumonic Effusion in Children: An Up-to-Date Review.EACTS expert consensus statement for surgical management of pleural empyema.Dose De-escalation of Intrapleural Tissue Plasminogen Activator Therapy for Pleural Infection. The Alteplase Dose Assessment for Pleural Infection Therapy Project.Perioperative implications of thoracic decortications: a retrospective cohort study.Pleural infection in a New Zealand centre: high incidence in Pacific people and RAPID score as a prognostic tool.Intrapleural Dornase and Tissue Plasminogen Activator in pediatric empyema (DTPA): a study protocol for a randomized controlled trial.Pediatric Pleural Empyema in the Province of Quebec: Analysis of a 10-Fold Increase Between 1990 and 2007.Empyema thoracisReal-time polymerase chain reaction for microbiological diagnosis of parapneumonic effusions in Canadian children.Chronic empyema: importance of preventing complications in the management of pleural effusionsEmpyema.Epidemiology of pleural infections in Taiwan from 1997 through 2008.La pneumonie pédiatrique complexe : le diagnostic et la prise en charge de l’empyème.L’empyème.Human pleural fluid is a potent growth medium for Streptococcus pneumoniae.Infectious pleural effusion status and treatment progress.Clinical characteristics and outcomes of patients with community-acquired, health-care-associated and hospital-acquired empyema.
P2860
Q26851796-7A4F6844-A476-48B1-9D38-02845D666CC9Q28071599-C8803A2B-13AB-4C4B-BAF5-0E8602956FE2Q28082543-0E5939F7-7541-41B9-8443-E7312B4DC53FQ28082965-197BEEA2-C9CD-49A0-8511-39614268964FQ30532487-1216CBD7-05FE-421F-A9FA-5D1C1184886BQ33351058-F1F06C74-FB3C-4BA5-8368-ACE92879AE69Q33985797-E33F27EE-92E5-4624-85F0-99DC60D5C483Q34140338-0451BE85-F340-460F-9F7E-3F3B96839213Q34407129-5E6B7464-35AD-41CC-8D88-F7E39166EAEBQ34612196-41EF7D31-9CF3-4632-88E8-642FDA7AC3B2Q34789889-C63AE9DB-E2A9-44FE-8823-08E611855175Q35434218-8D9716C1-231F-42E1-A06C-92331C469F6EQ36042320-CE83E31D-84EB-4B28-921B-A74EC7994496Q36137001-7133D989-F717-45C8-B621-5BFA677A338FQ36220140-CF509325-E217-4B2E-B1F1-F6A9970DAF25Q36763044-D69CF32F-962E-4C85-BCA6-07444DE18802Q36970232-1DE330E4-A1FA-4749-BC1A-2C358F06CB40Q37092926-0328EAD9-E1A5-4EFC-9707-CBD2D0FE440AQ37328702-810E1ED2-33DB-4A9D-BA84-7C9B5FD89EC2Q37793326-08A78B10-0E37-482F-8379-E8BC367E26C8Q37842778-4067E7B0-398C-495F-94D7-3179A607A637Q37850473-C5E97D2E-EDD3-4D63-9D8B-2168BBE83885Q38005699-0F91FF3D-4BAE-4978-A900-1C9E87760CA3Q38520923-DC8FF448-283B-477B-9C6B-D20C9E301B35Q38562868-95E875C5-D1C8-425A-A0EE-74D86F318D48Q38742124-C4287C7E-1EFD-4897-BFBD-8A553C28E949Q38792612-D477D2D2-7836-4D2A-B9D1-7A7EC99C658FQ38797008-8078B17F-95A6-440C-A16D-1A8718AB3A0BQ40051255-DEF31C70-7EC8-43ED-9277-8CB3713E8701Q40254594-C7D5E70B-7DE9-4F57-B2A9-5225F4914CE0Q41141522-F430AC5F-D261-4C70-BD9F-F86E7A3E2F4CQ41715337-5FC8194A-0AF7-456C-993C-3473D52C9A78Q41990709-3DE09FCE-E2CB-4CDA-8EF6-3A286C8FD001Q43134143-5F984246-5044-4826-A384-F24A67505D9BQ44622152-55A73079-33F1-4404-B7A9-C6035D228FE0Q45769624-082A41D5-C69F-42D6-A130-A1E840AB0535Q46139794-DA3C8663-A0F7-4508-908F-A72A9BDB4916Q47107555-0CA76B3A-52C0-4E90-AEFA-EC0E714B73F4Q47139064-4269C38B-8E93-4988-B5D4-2D83BCDEA345Q51570897-06AFF005-7E4F-484E-B128-7172C965C536
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Empyema: an increasing concern in Canada.
@en
Empyema: an increasing concern in Canada.
@nl
type
label
Empyema: an increasing concern in Canada.
@en
Empyema: an increasing concern in Canada.
@nl
prefLabel
Empyema: an increasing concern in Canada.
@en
Empyema: an increasing concern in Canada.
@nl
P2093
P2860
P356
P1476
Empyema: an increasing concern in Canada.
@en
P2093
Christian Finley
J Mark Fitzgerald
Joanne Clifton
P2860
P356
10.1155/2008/975312
P407
P577
2008-03-01T00:00:00Z